In Vitro and In Vivo Efficacy of Amphotericin B Combined with Posaconazole against Experimental Disseminated Sporotrichosis

Antimicrob Agents Chemother. 2015 Aug;59(8):5018-21. doi: 10.1128/AAC.00052-15. Epub 2015 May 26.

Abstract

We evaluated the combination of posaconazole with amphotericin B in vitro and in a murine model of systemic infections caused by Sporothrix brasiliensis and Sporothrix schenckii sensu stricto. In vitro data demonstrated a synergistic effect, and although posaconazole alone was effective against sporotrichosis, efficacy in terms of survival and burden reduction was increased with the combination. This combination might be an option against disseminated sporotrichosis, especially when itraconazole or amphotericin B at optimal doses are contraindicated.

MeSH terms

  • Amphotericin B / therapeutic use*
  • Animals
  • Antifungal Agents / therapeutic use*
  • Drug Resistance, Multiple, Fungal
  • Drug Therapy, Combination
  • Mice
  • Microbial Sensitivity Tests
  • Sporothrix / drug effects*
  • Sporothrix / pathogenicity
  • Sporotrichosis / drug therapy*
  • Triazoles / therapeutic use*

Substances

  • Antifungal Agents
  • Triazoles
  • posaconazole
  • Amphotericin B